Evaluation of three commercialized rapid point-of-care tests for detection of anti-hepatitis C virus antibodies in Burkina Faso

Ouedraogo H. Gautier1,2*, Ouandaogo H. Siaka2, Zida Sylvie1, Compaoré T. Rebeca1, Sagna Tani1, Sawadogo Salam3, Kouanda Seni1, Traoré Yves2 and Barro Nicolas

Seroprevalence and factors associated with IgG anti-DENV positivity in blood donors in Burkina Faso during the 2016 dengue outbreak and implications for blood supply

Salam Sawadogo, Adama Baguiya, Fiffou Yougbare, Brice Wilfried Bicaba, Koumpingnin Nebie, Tieba Millogo, Ibrahim Kamba, Losseni Kaba, Lassana Sangare, Eléonore Kafando, Véronique Deneys

Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso

Arzouma Paul Yooda,1–3 Salam Sawadogo,3 Serge Théophile Soubeiga,1,2 Dorcas Obiri-Yeboah,4 Koumpingnin Nebie,3 Abdoul Karim Ouattara,1,2 Birama Diarra,1,2 Abibou Simpore,3 Yetema Dieudonné Yonli,3 Abdoul- Guaniyi Sawadogo,3 Bia Emile Drabo,3 Seimbou Zalla,3 Anita Pierrette Siritié,3 Rodrigue Sosthène Nana,3 Honorine Dahourou,3 Jacques Simpore1,2

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Salam Sawadogo,corresponding author 1 , 2 Koumpingnin Nebie, 1 , 2 Tieba Millogo, 3 Sonia Sontie, 2 Ashmed Nana, 2 Honorine Dahourou, 2 Dieudonné Yentema Yonli, 2 Jean-Baptiste Tapko, 4 Jean-Claude Faber, 5 Eléonore Kafando, 1 and Véronique Deneys 6

Distribution of ABO and RHD blood group antigens in blood donors in Burkina Faso

Salam Sawadogo 1 2 , Koumpingnin Nebie 1 2 , Tieba Millogo 3 , Eléonore Kafando 1 , Abdoul-Guyani Sawadogo 2 , Honorine Dahourou 2 , Fauceny Traore 2 , Siaka Ouattara 2 , Oumarou Ouedraogo 2 , Kisito Kienou 2 , Yonli Yentema Dieudonné 2 , Véronique Deneys